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Case  reports  from  Johan  Czermak,  Marc  Ruffer,  and  others  a century  or more  ago  demonstrated  ancient
Egyptians  had  atherosclerosis  three  millennia  ago.  The  Horus  study  team  extended  their  ﬁndings,
demonstrating  that  atherosclerosis  was  prevalent  among  76  ancient  Egyptian  mummies  and  among  61
mummies  from  each  of  the  ancient  cultures  of  Peru,  the American  Southwest,  and  the Aleutian  Islands.
These  ﬁndings  challenge  the assumption  that  atherosclerosis  is  a modern  disease  caused  by  present  dayautopsy  of  an  ancient  Egyptian  teenage  male  weaver  named  Nakht  found  that  he
ummies




was infected  with  four  parasites:  Schistosoma  haematobium, Taenia  species,  Trichinella  spiralis,  and  Plas-
modium  falciparum.  Modern  day  patients  with  chronic  inﬂammatory  disease  such  as  rheumatoid  arthritis,
systemic  lupus  erythematosus,  and  human  immunodeﬁciency  virus  experience  premature  atherosclero-
sis. Could  the burden  of  chronic  inﬂammatory  disease  have  been  a risk  factor  for atherosclerosis  in these
ancient  cultures?  The  prevalence  of  atherosclerosis  in  four  diverse  ancient  cultures  is consistent  with
atherosclerosis  being  fundamental  to aging.  The  impact  of  risk  factors  in modern  times,  and  potentially
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in  ancient  times,  suggests  a strong  gene-environmental  interplay:  human  genes  provide  a vulnerability
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ntroduction
Why  do humans develop atherosclerosis? Is atherosclerosis
undamental to aging? Is it environmental? Chockalingam and col-
eagues suggest that classic risk factors account for 50% of the
ttributable risk of atherosclerosis [1]. Whereas Yusuf and col-
eagues argue risk factors account for a greater proportion of that
isk [2].
One of the ﬁrst to describe the importance of environmental
isk, the authors of the landmark Ni-Hon-San study of 1975 demon-
trated that among men  of Japanese ancestry, those living in Japan
Hiroshima and Nagasaki) had the lowest incidence of coronary
rtery disease (CAD), with increasing incidence in those living in
onolulu, and greater still among those living in the San Francisco
ay area [3]. Atherosclerosis was found to be present in humans
ong before modern civilization and present day risk factors. With
he help of computed tomography (CT) scanning, Murphy and col-
eagues demonstrated bilateral carotid calciﬁc atherosclerosis in
tzi the Iceman, a mummy  dating back to 3300 BCE [4] (BCE,
efore Common Era is equivalent to BC, Before Christ). Their dis-
overy represents the earliest documentation of atherosclerosis in
umans.
ioneering work
In 1852, Czermak was  the ﬁrst to report atherosclerosis in
ncient people [5]. Autopsying the mummy  of an elderly Egyptian
oman in Vienna, Austria, Czermak found “multiple considerably
arge and calciﬁed plaques” in her descending aorta. How does this
nding ﬁt into our current risk factor model of atherosclerosis?
hat risk factors would be present in this woman living along the
ile in ancient Egypt?
Czermak’s ﬁndings were conﬁrmed over ﬁfty years later by
arc Armand Ruffer, MD,  a bacteriologist who  trained with
ouis Pasteur. He found evidence of atherosclerosis on autopsy
f multiple Egyptian mummies and mummiﬁed limbs and pre-
ented his ﬁndings at the Cairo Scientiﬁc Society in December
908 [5,6]. Ruffer received these specimens from archeologi-
al colleagues who were asked to excavate ancient Egyptian
ombs prior to the expected downstream ﬂooding that would
ccur with the raising of the height of the Aswan Dam in 1907
7].
The brittleness of dehydrated mummies had bafﬂed previous
cientist’s autopsy attempts to create slides for microscopic analy-
is. Ruffer, however, determined that he could slowly rehydrate
Egyptian mummies. In his classic 1911 article [8], Ruffer stated,
“In my  opinion, therefore, the old Egyptians suffered as much
as we  do from arterial lesions identical with those found in the
present time. Moreover, when we  consider that few of the arter-
ies examined were quite healthy, it would appear that such lesions
were as frequent 3,000 years ago as they are today.” He thus con-
cluded, “I can not therefore give any reason why arterial disease
should have been so prevalent in ancient Egypt. I think, how-
ever, that it is interesting to ﬁnd that it was  common and that
3,000 years ago it represented the same anatomic characters as
it does now.”
Horus study team investigations
A century following Ruffer’s landmark work [9], the Horus study
team formed to evaluate the presence, extent, and potential eti-
ologies of atherosclerosis in Egyptian and non-Egyptian ancient
peoples. The team has since grown to become an international mul-
tidisciplinary group of physicians and scientists that includes the
authors of this paper and other members. The team’s namesake
(Horus) is one of the oldest and most signiﬁcant deities of ancient
Egypt. One of Horus’ many tasks was that of protector. His depic-
tion as falcon made of gold serves as a breastplate for many royal
Egyptian mummies (Fig. 1).
Using a Siemens Emotion 6 slice CT scanner (Florsheim,
Germany) on site at the Egyptian National Museum of Antiquities
in Cairo, Egypt in February 2009, the initial Horus team imaged 20
mummies and was  provided the CT scans of two  others [10–12].
The CT scanner was initially donated by Siemens and the National
Geographic Society to image Pharaoh Tutankhamun. The team usedhe tissue by its immersion in a solution composed of an alkali
alt and alcohol of varying concentrations over several days. This
ehydration process allowed microtome sectioning of the fragile
issue and demonstrated calciﬁc atherosclerosis to be common inFig. 1. The deity Horus depicted as a falcon, the breastplate of Tjanefer of Thebes,
and the Third intermediate period (1080–712 BCE). Mummy  9 of Thompson and
colleagues [17].












































Fig. 3. Coronary calciﬁcations in the mummy of a Unangan woman  aged 47–51E.M. Clarke et al. / Journal o
rterial calciﬁcation as a pathognomonic marker of atherosclerosis
13]. Calciﬁcation in the wall of a clearly identiﬁable artery was
abeled diagnostic of atherosclerosis, calciﬁcation along an artery’s
xpected course was labeled as probable atherosclerosis [10]. To
he team’s surprise, deﬁnite atherosclerosis was present in 5 and
robable in 4 out of the 22 scanned mummies.
A larger team returned to Egypt in May  2010 to scan 22 more
ummies and review the CT scans of 8 additional mummies which
ere provided to them. Mummies now totaled 52. Of these, 20
ad deﬁnite or probable atherosclerosis [14]. One of the mummies
maged was Princess Ahmose-Meryet-Amon, the daughter of 17th
ynasty Pharaoh Seqenenre Tao II and his wife Queen Ahhotep I.
he Princess’ half brother, Ahmose I, became the ﬁrst Pharaoh of the
ew Kingdom, the Golden Age of Egypt. When Princess Ahmose-
eryet-Amon died at an estimated age of 40–45 years, she had
therosclerosis of all her major vascular beds, including her right
oronary and left anterior descending coronary arteries (Fig. 2). She
s thus far the earliest human in history with CAD. Prior to this
iscovery, the earliest recorded case of CAD was by Allen Long, MD
n 1931 of Lady Teye, who lived during the 21st dynasty, circa. 1000
CE [15].
Following the Egyptian revolution of 2011, the Horus team
ransitioned to imaging mummies in Lima, Peru. The work of
uido P. Lombardi, MD,  MA and Clide M.  Vallodolid resulted in
he provision for the scanning of 51 ancient Peruvian mummies
rom the Museo de Sitio Puruchuco – Arturo Jimenez Borja. These
ncient Peruvians lived between 900 BCE and 1500 CE on or near
he coast of modern day Lima. Without written word until the
rrival of the Spanish in 1524, they were prehistoric people who
ere farmers who kept guinea pigs and other domestic animals as
ources of meat [16]. Of these 51 mummies, 13 (25%) had deﬁnite or
robable atherosclerosis [17], with a nonsigniﬁcant trend toward
ess atherosclerosis than in the Egyptian samples. Ancient Peru-
ians had been naturally mummiﬁed, simply dried in the desert
un without evisceration of the abdominal cavity. Such evisceration
nd other techniques were key components of Egyptian mummiﬁ-
ation designed to decrease putrefaction. Thus, the difference may
ave been related to less effective arterial and organ preservation
n the Peruvians rather than a true difference in the prevalence of
therosclerosis. Environment and lifestyles did differ between the
ultures, however.
ig. 2. Coronary artery calciﬁcations in the mummy  of Ahmose-Meritamun of
hebes, an Egyptian princess aged 40–45 years who  lived about 1580–1550 BCE
sagittal oblique 3D volume rendered image). Mummy  35 of Thompson and col-
eagues [17]. RCA, right coronary artery. Reprinted with permission.years who lived in the late 19th century CE and was found in a cave on Kagamil
Island of the Aleutian Islands (sagittal three-dimensional volume rendered image).
Mummy  133 of Thompson and colleagues [17].
Janet Monge, PhD of the University of Pennsylvania Department
of Anthropology and Museum of Archaeology and Anthropol-
ogy arranged for the team to review the whole body CT images
of ﬁve Ancestral Puebloan Native American mummies excavated
from Southeast Utah and southwestern Colorado 120 years ago.
They lived between 1500 BCE and 1500 CE and were likely
forager–farmers [18]. Like the Peruvians, they predated the written
word and were thus a prehistoric culture. One of the ﬁve mummies
had deﬁnite atherosclerosis, another probable atherosclerosis [17].
Bruno Frohlich, PhD and colleagues at the Smithsonian Institu-
tion arranged for the review of the whole body CT scans of ﬁve
Unangan mummies who  lived in the Aleutian Islands between
1756 and 1930 CE. The Unangans were hunter–gatherers, with-
out agriculture or domesticated animals [19]. Like the Ancestral
Puebloans, individuals of their era lived in subterranean earthen
homes in which ﬁre used for cooking and light would have resulted
in an often smoky household. Three of the ﬁve mummies had def-
inite atherosclerosis. This included a 40–44-year-old woman with
atherosclerosis of the right coronary artery, aorta, and periph-
eral arteries (Fig. 3). To our knowledge, she represents the ﬁrst
hunter–gatherer diagnosed with CAD [17].
As would be expected, these ancient peoples often died young.
The mean age at death of all 137 mummies in the Horus cohort was
36 (SD 15) years. We  acknowledge that the uncertainty of skeletal
age dates may  be >10 years for middle-aged and older specimens.
Gender could be determined for 121 mummies; 77 were male and
44 female. Presence of atherosclerosis was  speciﬁcally evaluated
in ﬁve vascular beds: carotids, coronary, aorta, iliofemoral arter-
ies, and popliteal/tibial arteries. The mean age of those without
atherosclerosis was 32 (SD 15) years. For those with atherosclero-
sis of one to two beds, the mean age was 42 (SD 10) years and those
with atherosclerosis of three to ﬁve beds, 44 (SD 8) years (p < 0.001)
[17]. There was a nonsigniﬁcant trend in this cohort toward more
extensive atherosclerosis among women.
Discussion
Why  would atherosclerosis be so prevalent among four cul-
tures with such diverse diets and lifestyles? Chan and Boerwinkle
estimate that human genetics predict approximately 50% of the
prevalence for CAD, for example [20]. The ﬁndings of the Horus
team and those of previous paleopathology researchers are con-
sistent with a substantial innate vulnerability of humans to
atherosclerosis. The epidemiologic and clinical work of thousands
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ifestyle, and their impact on currently understood risk factors, con-
ribute greatly to whether this vulnerability results in clinically
pparent atherosclerosis or via imaging techniques.
Referring back to the question raised in the introduction, is
therosclerosis a fundamental component of human aging? Our
nding that atherosclerosis is common to four diverse popula-
ions is consistent with the hypothesis that atherosclerosis is
ndeed fundamental to aging. Studies by Lakatta and others sug-
est that arterial degeneration begins early in postnatal life and
s progressive in all human populations for which there is post-
ortem analysis [21]. However, the degree of atherosclerosis can
e delayed by a lifelong avoidance of lifestyle risk factors [22] or
he genetic luck of having an abundance of low-density lipoprotein
LDL) receptors secondary to a loss of function single nucleotide
olymorphism for PCSK9 and thus a lifetime of low LDL cholesterol
23]. A synthesis of these ﬁndings is consistent with a strong gene-
nvironmental interplay. Vulnerability to atherosclerosis is hard
ired into the human genome with a substantial environmental,
n this case, risk factor related, inﬂuence.
With the 1961 coining of the phrase “factors of risk” by Kannel
t al. [24] and the conﬁrmation of their importance in the devel-
pment of CAD in the Framingham and many other populations,
linicians now rely on their characterization and quantitation to
redict and try to alter atherosclerosis risk [25]. Yet have we fully
haracterized all key risk factors involved? Researchers have care-
ully evaluated what is currently measurable by laboratory and
ther tests in the prediction of atherosclerosis. But what of pro-
esses we currently do not have the knowledge to measure? Why
ould our current medical knowledge necessarily include the abil-
ty to measure all physiologic or other factors that increase the risk
f atherosclerosis?
An inﬂammatory disease, atherosclerosis occurs prematurely
n those with chronic inﬂammatory diseases such as rheumatoid
rthritis (RA) and systemic lupus erythematosus [26]. Sta-
atelopoulos and colleagues found cardiovascular risk in RA to be
omparable to the risk reported in patients with diabetes mellitus of
imilar disease duration [27]. CAD also occurs prematurely in those
ith human immunodeﬁciency virus, another chronic inﬂamma-
ory disease [28].
Fig. 4. Mummy  of Nakht, an Egyptian teenage boy of the New Kingdom [3
ig. 5. Painted anthropoid cofﬁn of Nakht. Hieroglyphics on the cofﬁn indicate that he w
ynasty [33]. Reprinted with permission of the Royal Ontario Museum © ROM.iology 63 (2014) 329–334
Acute infection has also been found to play a role in the expres-
sion of atherosclerosis in individuals following inﬂuenza infections
[29] or by its relative avoidance following immunization [30].
The environments in which these ancient persons lived pre-
dated the understanding of germ theory, modern hygiene, and
antibiotics. Infection, and thus inﬂammation, was likely rampant
[31].
This makes the proﬁling of infectious agents undertaken during
one of the most sophisticated mummy  autopsies ever performed,
particularly important. In August 1974, a dozen Canadian-, US-, and
British-based physicians, scientists, and technologists assembled
for a carefully planned two-day autopsy of Nakht, the mummy
of an Egyptian boy in his mid-teens [32]. The setting was  the
Anatomy Department of the Medical Sciences Building of the Uni-
versity of Toronto. Autopsy tools had evolved since the time of
Ruffer, who only had a light microscope available. An early scan-
ning electron microscope was  one of these new tools, capable of
magnifying tissue 1000 times greater than Ruffer had at his dis-
posal [33]. Following the gross autopsy, tissues were directed to
various laboratories of the team for more in-depth analyses. San-
dison’s modiﬁcation of Ruffer’s solution and other methods were
used to rehydrate the tissue [34,35].
Identiﬁed by the hieroglyphics on his cofﬁn as a weaver, he
lived in Thebes, now the city of Luxor, during the last century of
the New Kingdom (Fig. 4) [33]. Hieroglyphics on the cofﬁn indicate
that he worked in the temple of Pharaoh Setnakth, the ﬁrst ruler
of the 20th Dynasty (Fig. 5). Pharaoh Setnakth died circa. 1198 BCE
[35].
As a weaver, Nakht would have sewn linen, the common cloth
of the time, from the ﬁber of the local ﬂax plant. In death, he was
wrapped in linen badges and two linen robes. Nakht is depicted on
the lid of his painted anthropoid cofﬁn wearing a long wig  striped in
blue [36]. Pre-autopsy radiographs found that his mummiﬁcation
had not been typical of ancient Egyptians [37]. Like the Peruvian
mummies, he had simply been dried out in the desert sun, in this
case along the Nile, without evisceration or traditional preservation
methods. As a dehydrated mummy, he weighed only 5.1 kg and
was 1.4 m tall [33]. Excavated houses of Nakht’s era suggest that
commoners such as a weaver would likely have lived in a two- or
3]. Reprinted with permission of the Royal Ontario Museum © ROM.
orked as a weaver in the time of the Pharaoh Setnakth, the ﬁrst ruler of the 20th
E.M. Clarke et al. / Journal of Cardiology 63 (2014) 329–334 333




















amall  intestine, kidney, and bladder [35]. Reprinted with the permission of Cambrid
35,42]. (C) Trichinella spiralis, found in an intercostal muscle. Reprinted with the 
ntigen immunoassay [35]. This image was  not found in Nakht but is a representati
hree-room mud  brick house with a ﬂat roof of earth on rafters of
alm logs. Cooking was carried out in an outside courtyard or on
he roof [33,36].
A diverse diet was available during the New Kingdom. Eggs,
utter, milk, lettuce, honey, cucumber, garlic, spices, dates, lentils,
rapes, and ﬁgs have been retrieved from archeologic ﬁnds. Beer
nd wine, ﬁsh, domesticated cattle, sheep, pigs, and fowl were also
nown to be available [38–40].
The histologic and hematologic ﬁndings of the autopsy were
emarkable, young Nakht was infected with four different parasites
41] (Fig. 6):
1) Schistosoma species were found in his liver, large and small
bowel, kidney, and bladder. His bladder contained red blood
cells, consistent with hematuria characteristic of infection by
Schistosoma haematobium [42]. Schistosomiasis is endemic in
modern-day Egypt.
2) Taenia species (tapeworm) ova were present in his small and
large intestine. Adult worms, which can grow many meters
long, were not found [42].
3) Trichinella spiralis,  suggestive of undercooked pork consump-
tion, was found in an intercostal muscle [43].
4) Plasmodium falciparum,  which causes malaria, was identiﬁed by
antigen immunoassay two decades later when this technique
was available [41].
One of the authors (DEM), a mid-career pediatric infectious dis-
ase specialist practicing in the USA, has never knowingly cared for patient with four different parasites.
In another autopsy ﬁnding relevant to atherosclerosis, like
ost Egyptian mummies, Nakht had substantial pulmonary
nthracosis – carbon deposition in the lungs from smoke. Thisiversity Press. (B) Taenia species (tapeworm), found in his large and small intestine
ssion of Cambridge University Press [35]. (D) Plasmodium falciparum identiﬁed by
age of the parasite.
exposure could represent an unexpected risk factor for the devel-
opment of atherosclerosis [17,44,45]. The trend toward more
extensive atherosclerosis in women  is of note, as women held
a traditional role that included cooking in each of the four
cultures.
While not found during the evaluation of Nakht, Zink and
colleagues determined by ancient DNA analysis that tuberculo-
sis was common in ancient Thebes. Among 85 Thebean Egyptian
mummies, ca. 2050 BCE to ca. 500 BCE, 48 had ampliﬁable ancient
DNA. Of these, 25 had tuberculosis. This analytic DNA tech-
nique had not been developed at the time of Nakht’s autopsy
[46].
Chronic infections were not limited to commoners of ancient
civilizations. Arguably the most famous of all mummies, Pharaoh
Tutankhamun, reigned during the 18th dynasty of the New King-
dom and died at the age of 19 ca.1324 BCE. Like Nakht, molecular
analysis demonstrated that he had malaria, in Tutankhamen’s case,
he had two  different strains of P. falciparum,  the parasite that causes
malaria [47].
If Nakht is at all representative of ancient Egyptians, and
potentially other ancient cultures, a lifelong inﬂammatory burden
analogous to modern day chronic inﬂammatory diseases, may rep-
resent a decisive risk factor in the development of atherosclerosis
[31,48–51].
Other yet to be discovered risk factors or etiologies could also
be causal for the development of atherosclerosis in these ancient
cultures. Further work in this ﬁeld could provide rich rewards.Conclusion
Insights from paleopathology suggest that our knowledge of risk






















































[34 E.M. Clarke et al. / Journal o
nﬂammatory burden may  have played a greater role in ancient
ultures than previously appreciated. While increasingly prevalent
ith age in ancient and modern cultures, a synthesis of the work
eviewed is consistent with a strong gene-environmental interplay
n the development of atherosclerosis across the lifespan. While
enes create the vulnerability, the environment determines when
nd if atherosclerosis becomes manifest clinically.
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